Strategy

European biopharma forecasts for 2024

Read more

Caszyme pioneers gene editing from Lithuania

Read more

Zealand Pharma maps out strategy for obesity

Read more

The weight loss sector continues to evolve

Read more

Unlocking value in pharma R&D

Read more

Raising the threshold: argenx predicts continued market expansion

Read more

Provincialism holds back Europe's biotech sector

Read more

Changes in the landscape for genome editing

Read more

A new therapeutic approach for IgA nephropathy

Read more

Swiss biotech helped by international deals, drug wins, By Jane Morrison

Read more